CD8-predominant AITL exhibited a higher CD30 positive rate (median: 20%, range: 0–30%, P = 0.020) and Ki67 index (median: 60%, range: 50–70%, P = 0.041) than common AITL. The gene discussed is CD8A; the disease is angioimmunoblastic T-cell lymphoma.